Predicting New-onset Post-stroke Depression from Real-world Data Using Machine Learning Algorithm
Overview
Authors
Affiliations
Introduction: Post-stroke depression (PSD) is a serious mental disorder after ischemic stroke. Early detection is important for clinical practice. This research aims to develop machine learning models to predict new-onset PSD using real-world data.
Methods: We collected data for ischemic stroke patients from multiple medical institutions in Taiwan between 2001 and 2019. We developed models from 61,460 patients and used 15,366 independent patients to test the models' performance by evaluating their specificities and sensitivities. The predicted targets were whether PSD occurred at 30, 90, 180, and 365 days post-stroke. We ranked the important clinical features in these models.
Results: In the study's database sample, 1.3% of patients were diagnosed with PSD. The average specificity and sensitivity of these four models were 0.83-0.91 and 0.30-0.48, respectively. Ten features were listed as important features related to PSD at different time points, namely old age, high height, low weight post-stroke, higher diastolic blood pressure after stroke, no pre-stroke hypertension but post-stroke hypertension (new-onset hypertension), post-stroke sleep-wake disorders, post-stroke anxiety disorders, post-stroke hemiplegia, and lower blood urea nitrogen during stroke.
Discussion: Machine learning models can provide as potential predictive tools for PSD and important factors are identified to alert clinicians for early detection of depression in high-risk stroke patients.
Xiao A, Wang R, Liu C, Wang X BMC Neurol. 2025; 25(1):104.
PMID: 40075309 PMC: 11900648. DOI: 10.1186/s12883-025-04090-y.
Risk Factors for Post-Stroke Depression Following the Lifting of COVID-19 Restrictions.
Luo S, Hu X, Hong Y, Gao Y, Liu X, Peng Y Int J Gen Med. 2024; 17:3479-3491.
PMID: 39161406 PMC: 11331147. DOI: 10.2147/IJGM.S472339.
Machine Learning Models and Applications for Early Detection.
Zapata-Cortes O, Arango-Serna M, Zapata-Cortes J, Restrepo-Carmona J Sensors (Basel). 2024; 24(14).
PMID: 39066075 PMC: 11280754. DOI: 10.3390/s24144678.
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications.
Zhang S, Pu Y, Liu J, Li L, An C, Wu Y Front Pharmacol. 2024; 15:1337749.
PMID: 38666026 PMC: 11043571. DOI: 10.3389/fphar.2024.1337749.
Oei C, Ng E, Ng M, Tan R, Chan Y, Chan L Sensors (Basel). 2023; 23(18).
PMID: 37766004 PMC: 10538068. DOI: 10.3390/s23187946.